Computer-assisted method development and optimization in high-performance liquid chromatography

Similar documents
Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC

Technical Overview. Author. Abstract. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany

Analysis of TCM injections using the Agilent 1290 Infinity LC system

Peptide Mapping: A Quality by Design (QbD) Approach

The Theory of HPLC Gradient HPLC

Method Translation in Liquid Chromatography

Reversed-phase Separation of Intact Monoclonal Antibodies Using Agilent ZORBAX Rapid Resolution High Definition 300SB-C8 1.

Application Note. Biopharma. Authors. Abstract. James Martosella, Phu Duong Agilent Technologies, Inc Centreville Rd Wilmington, DE 19808

Bivalirudin Purification:

HPLC to UPLC Method Migration: An Overview of Key Considerations and Available Tools

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column

ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS

ZORBAX StableBond HPLC Columns

An Automated System for At-Line Process Analysis of Biopharmaceutical Fermentation Reactions

Effect of Peak Symmetry Analytical Figures of Merit Used in Pharmaceutical Validation

Application Note. Author. Abstract. Small Molecule Pharmaceuticals. Sonja Krieger Agilent Technologies, Inc. Waldbronn, Germany

Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC

ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS

Improving Resolution and Column Loading Systematically in Preparative Liquid Chromatography for Isolating a Minor Component from Peppermint Extract

Optimizing Purified Sample Recovery on Reverse-Phase HPLC Systems

High-Resolution Charge Variant Analysis for Top-Selling Monoclonal Antibody Therapeutics Using a Linear ph Gradient Separation Platform

Protein-Pak Hi Res HIC Column and HIC Protein Standard

R R Innovation Way P/N SECKIT-7830 Newark, DE 19711, USA Tel: Fax: Website: Published in November 2013

EPA Method 543: Selected Organic Contaminants by Online SPE LC/MS/MS Using the Agilent Flexible Cube

Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column

Preparative Purification of Corticosteroids by HPLC; Scalability and Loadability Using Agilent Prep C18 HPLC Columns Application

HIC as a Complementary, Confirmatory Tool to SEC for the Analysis of mab Aggregates

Analytical Instrument Qualification According to USP <1058>: Requirements and Examples for the Agilent 1290 Infinity LC System

Analysis of amoxicillin and five impurities on the Agilent 1220 Infinity LC System

Analysis and Purification of Polypeptides by Reversed-Phase HPLC

APPLICATIONS TN Overview of Kinetex 2.6 µm Core-Shell Technology

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Improved SPE for UPLC/MS Determination of Diquat and Paraquat in Environmental

A Practical User Guide for the Determination of Optimal Purification Gradients for the Gilson PLC 2020

Chem 321 Lecture 23 - Liquid Chromatography 11/19/13

Fast Preparative Column Liquid Chromatography (PCLC)

Optimizing the Purification of a Standard Chiral Compound Utilizing a Benchtop, Multi-Purpose, Semi-Preparative to Preparative HPLC System

Qualification of High-Performance Liquid Chromatography Systems

Application Note. Authors. Abstract. Biopharmaceuticals

Overview of preparative HPLC. Analytical Technologies Limited

A universal chromatography method for aggregate analysis of monoclonal antibodies

Agilent AdvanceBio SEC Columns for Aggregate Analysis: Instrument Compatibility

Practical Examination of a Nonporous Silica Stationary Phase for Reversed-Phase Fast LC Applications

Improved Peptide Maps Using Core-Shell Media: Explaining Better Biopharmaceutical Applications With Kinetex C18 Columns

Physical Stability of a Silica- Based Size Exclusion Column for Antibody Analysis

Development of Analysis Methods for Therapeutic Monoclonal Antibodies Using Innovative Superficially Porous Particle Biocolumns

AppNote 5/2006 ABSTRACT

PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC

Gold Standard for recovery and purity

Protein Separation with ph Gradients Using Composite Buffer Systems Calculated by the Agilent Buffer Advisor Software

High Temperature Liquid Chromatography

Comparison Guide. Comparison Data on Commonly Used C18 Phases TO C18 REVERSED P HASE HPLC COLUMNS. Stationary Phase Specifications

*Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy, Damascus University, Mazzeh Street, Damascus, Syrian Arab Republic.

easy. HPLC has never been so Agilent 1120 Compact LC Our measure is your success.

Determination of Adenovirus pviii (31K) Concentration for Estimation of the Empty Capsid Concentration of the Adenovirus Reference Material (ARM)

AdvancedTools in HPLC methoddevelopment

Technical Overview. Author. Abstract. A.G.Huesgen Agilent Technologies, Inc. Waldbronn, Germany

Fraction Analysis of Cysteine Linked Antibody-Drug Conjugates Using Hydrophobic Interaction. chromatography. Agilent 1260 Infinity II Bio-Inert System

RP-HPLC METHOD FOR QUANTITATIVE ESTIMATION OF GLATIRAMER ACETATE FOR INJECTION IN PHARMACEUTICAL DOSAGE FORMS

Technical Note. Introduction

A Comprehensive Workflow to Optimize and Execute Protein Aggregate Studies

Preparative HPLC is still the

Concentration of Human Hormones in Drinking Water Using Solid Phase Extraction and Analysis by High Performance Liquid Chromatography

ISSN India; g,secunderabad. Abstractt. a flow rate. of 1ml/min. di hydrogen. which acts. and chronic. including minimize (5) Figure

Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus

Application Note. Author. Abstract. Biopharmaceuticals. Verified for Agilent 1260 Infinity II LC Bio-inert System. Sonja Schneider

Quality by Design (QbD) Based Development of a Stability Indicating HPLC Method for Drug and Impurities

mab Titer Analysis with the Agilent Bio-Monolith Protein A Column

Heart-cut 2D-LC/MS approach for pharmaceutical impurity identification using an Agilent 6540 Q-TOF LC/MS System

BioHPLC columns. Tim Rice Biocolumn Technical Specialist

Characterization of mab aggregation using a Cary 60 UV-Vis Spectrophotometer and the Agilent 1260 Infinity LC system

Controlling Agilent 1200 Series Rapid Resolution LC systems through Waters Empower chromatography data software. Technical Overview.

A Brief Overview of HPLC & UHPLC Method Development and Optimization. Dr. Chris Message UHPLC/HPLC Product Specialist Phenomenex

Enhancing your HPLC Separations using Temperature Programming

Genotoxicity is the property of a compound

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON ARTEMETHER AND LUMEFANTRINE CAPSULES REVISED DRAFT FOR DISCUSSION

High-throughput and Sensitive Size Exclusion Chromatography (SEC) of Biologics Using Agilent AdvanceBio SEC Columns

Application Note. Abstract. Authors. Introduction. Environmental

Application of Agilent AdvanceBio Desalting-RP Cartridges for LC/MS Analysis of mabs A One- and Two-dimensional LC/MS Study

Ultrapure water: LC-MS suitability tests

High Resolution Analysis of Heparin and Heparin-like Impurities on Glycomix TM an Anion Exchange Column

Int. J. Pharm. Sci. Rev. Res., 31(1), March April 2015; Article No. 20, Pages: Comparison of UPLC with UFLC: Liquid Chromatography

Preparative HPLC: Factors and Parameters that Directly Affect Recovery of Collected Fractions

Research Paper Development of Stability Indicating Reverse Phase HPLC Method for Aripiprazole from Solid Dosage form

Fast and High Resolution Analysis of Intact and Reduced Therapeutic Monoclonal Antibodies (mabs)

Reversed-Phase HPLC Columns

A Modular Preparative HPLC System for the Isolation of Puerarin from Kudzu Root Extracts

Fundamentals and Techniques of Preparative HPLC. Parto Zist Behboud Tel: 42108

Forced Degradation of Ibuprofen in Bulk Drug and Tablets

7 Preparative Columns

Zwitterion Chromatography ZIC

Biomolecule Purification. Purification columns and media for peptides, oligonucleotides, and proteins

Preparative, Pilot & Process Columns

Separation of Recombinant Human Erythropoietin (repo) Using Agilent Bio SEC-3

Exploring Extra Sensitivity Using ionkey/ms with the Xevo G2-XS Q-Tof HRMS for Small Molecule Pharmaceutical Analysis in Human Plasma

Fast and High-Resolution Reversed-Phase Separation of Synthetic Oligonucleotides

Promix TM. Enter a New Era in Biomolecule Analysis with. Columns. Unsurpassed Selectivity and Peak Capacity for Peptides and Proteins

Reproducible preparative liquid chromatography columns

Isocratic and gradient elution chromatography: A comparison in terms of speed, retention reproducibility and quantitation

Agilent MetaCarb Ca PLUS Carbohydrate Column Ca ++ Form User Manual Part No. A5205

Transcription:

Journal of Chromatography A, 991 (2003) 281 287 www.elsevier.com/ locate/ chroma Short communication Computer-assisted method development and optimization in high-performance liquid chromatography * T.H. Hoang, D. Cuerrier, S. McClintock, M. Di Maso Department of Pharmaceutical Research and Development, Merck Frosst Canada & Co., P.O. Box 1005, Pointe Claire-Dorval, Quebec, Canada H9R 4P8 Received 25 November 2002; received in revised form 22 January 2003; accepted 22 January 2003 Abstract This paper reports the use of DryLab, a computer simulation software package, to assist in the development and optimization of a reversed-phase high-performance liquid chromatographic (HPLC) method for the separation of a model drug candidate and its degradation products. Prior to the optimization process, columns with various bonded phases are evaluated for their chromatographic performance using the sample of interest. Simultaneous optimization of two separation variables and the use of resolution maps to predict the optimal conditions are illustrated. Options to optimize column conditions (column length and flow-rate) to further reduce run time are briefly discussed. The accuracy of DryLab-predicted retention times and resolution is compared with experimental values. The DryLab software used in this study provided satisfactory predictions for the selected model, with average errors of less than 3.5 and 11.8% for retention time and resolution, respectively. 2003 Elsevier Science B.V. All rights reserved. Keywords: Computer-assisted optimization; Computer simulation; DryLab 1. Introduction process, several computer simulation software packages have been introduced [1,2]. With a limited A major challenge in the development of chro- number of experimental runs, chromatographers can matographic separation methods is the rational selec- model changes in experimental conditions, optimize tion of optimal experimental conditions that can method conditions and predict method robustness provide an adequate resolution and a reasonable run [3 5]. time. This task becomes more complicated with an In the present study, a computer simulation softincreasing number of operating variables and conse- ware (DryLab) was employed in developing a requently requires a larger number of experimental versed-phase HPLC separation of a drug candidate runs. To simplify and accelerate the optimization (Compound I) and its degradation products (Fig. 1). The importance of the evaluation of columns using the sample of interest prior to optimization process is *Corresponding author. Tel.: 11-514-428-3382; fax: 11-514- emphasized. Features that allow simultaneous op- 428-2855. timization of two variables and optimization of E-mail address: thanh hoang@merck.com (T.H. Hoang). ] column conditions are discussed. Comparisons of 0021-9673/03/$ see front matter 2003 Elsevier Science B.V. All rights reserved. doi:10.1016/ S0021-9673(03)00206-1

282 T.H. Hoang et al. / J. Chromatogr. A 991 (2003) 281 287 Science, Gibbstown, NJ, USA), ammonium formate, ammonium acetate (American Chemicals, Montreal, QC, Canada) and trifluoroacetic acid (TFA), sequanal grade (Pierce, IL, USA) were used. Standard solutions of Compound I (Merck & Co. Inc., Rahway, NJ, USA) were prepared in water methanol (25:75, v/ v) at a concentration of 0.2 mg/ml, The standard solution was exposed to light (30 min) for generation of peak 3 and then spiked with authentic standards of degradation products (peaks 1, 2 and 4). Fig. 1. Functional structural scheme of model drug candidate (Compound I) and its degradation products. 3. Results and discussion 3.1. Selection of columns predicted and experimental values for selected separation conditions are also examined. The model compound and its degradation products used in this study are weak acids, except for one (peak 4) where the acidic functional group is absent (Fig. 1). Due to the ionic character of the model compounds, TFA was added to the mobile phase to 2. Experimental provide an acidic medium and to minimize adverse ionic interactions between analytes and residual 2.1. Equipment and software silanol groups of the silica backbone. Columns with various bonded phases were evaluated for optimum Chromatographic measurements were made on a capacity factor (k9), plate number (N) and tailing HP1100 Series HPLC system (Agilent Technologies, factor. The organic content of the mobile phase and Palo Alto, CA, USA) equipped with a binary pump, flow-rate were varied to accommodate the differa vacuum degasser module, an autosampler with ences in the nature of the bonded phase and column injection volume of 5 ml, a temperature-controlled dimension. The results (Table 1) suggested the YMC column compartment and a variable wavelength UV ODS-AM column as the best choice since it provided detector set at 220 nm. excellent peak symmetry, appropriate k9 range and Multichrom chromatography data system, version greatest plate number. The results also emphasize the 2.1-1 (Thermo LabSystems, Cheshire, UK) was used fact that the chromatographic information about to acquire the chromatographic data. different phases supplied by many HPLC column Retention times and peak areas of individual peaks manufacturers using their test probes and protocols from experimental runs were used as input data for may not reflect the performance using the sample of Drylab Software for Chromatography Modeling, interest. Columns must be screened using the actual version 3.0.09 (LC Resources, Walnut Creek, CA, sample to select the most appropriate for the sepa- USA). ration. HPLC columns evaluated in this study were purchased from YMC (Milford, MA, USA) and 3.2. Experimental designs Agilent Technologies (Palo Alto, CA, USA). Since the Drylab software allows for simultaneous 2.2. Materials optimization of only two variables in a given set of optimization variables, three combinations are pos- Milli-Q water (Millipore, Bedford, MA, USA), HPLC-grade Omnisolve acetonitrile, methanol (EM sible in this study, based on organic content, ph and column temperature. They include organic content/

T.H. Hoang et al. / J. Chromatogr. A 991 (2003) 281 287 283 Table 1 Initial conditions and evaluation criteria for selection of columns a a Columns %B Flow-rate k9 Tailing Plate (ml/ min) range (N) YMC ODS-AM 45 1.5 4.5 22 1.04 17 000 (3 mm, 15034.6 mm I.D.) Zorbax SB-CN 38 1.0 4.0 12 1.71 6000 (3.5 mm, 7534.6 mm I.D.) Zorbax SB-phenyl 35 1.5 8.5 27 0.73 4000 (5 mm, 15033.0 mm I.D.) Zorbax SB-C18 42 1.0 5.5 27 1.13 8000 (3.5 mm, 7534.6 mm I.D.) Zorbax XDB-C18 42 1.0 5.5 31 1.06 8000 (3.5 mm, 7534.6 mm I.D.) a Calculated using the main peak. column temperature, organic content/ ph and column set at 1.5 ml/ min. The experimental design for this temperature/ ph. The last combination has been combination is illustrated in Fig. 2A. reported to be less satisfactory in controlling selec- The result is shown as a resolution map (Fig. 3), tivity and maximizing resolution [5]. Two combina- where the smallest value of resolution (R s) of any tions of organic content/ column temperature and two critical peaks in the chromatogram is plotted as a organic content/ ph were selected for this study. Fig. function of two simultaneously varied experimental 2 shows the experimental designs and the number of parameters. A maximal Rs of greater than 4 was experiments required for each combination. obtained at higher column temperature and low %B (,30%) at the cost of a long run time (.250 min, not shown on the resolution map). An Rs of less than 3.3. Simultaneous optimization of organic content 1.5 and a significantly shorter run time were obtained (%B) and column temperature when organic content exceeds 48%, regardless of column temperature. An optimal Rs of at least 2.0 Simultaneous optimization of organic content and a run time of less than 40 min was obtained at (%B) and column temperature was first performed 41 45% B and at 50 8C. Table 2 shows a comusing a YMC ODS-AM, 3 mm, 15034.6 mm I.D. parison of predicted and experimental data for the column with aqueous acetonitrile modified with optimized separation at 44% B and column tempera- 0.1% TFA as the mobile phase. The flow-rate was ture at 50 8C. A good agreement between the predicted and experimental values was obtained, with average errors of 0.8 and 6.6% for retention time and resolution, respectively. Additional optimization was performed with a column temperature of 50 8C and higher organic content to reduce the run time is described in the following section. 3.4. Simultaneous optimization of organic content (%B) and ph Fig. 2. Experimental designs for simultaneous optimization of (A) organic content/ column temperature and (B) organic content/ ph. Experimental design for simultaneous optimization of %B and ph requires six experiments, as illustrated in Fig. 2B. The mobile phase consisted of (a) 25 mm ammonium formate (ph 3.0) or (b) 25 mm ammonium acetate (ph 4.0 and 5.0) and acetonitrile as

284 T.H. Hoang et al. / J. Chromatogr. A 991 (2003) 281 287 Fig. 3. Resolution map obtained with simultaneous optimization of organic content and column temperature. Cross-hair marks the region with optimal R. s Table 2 A comparison of predicted and experimental data for the opti- mized separation of model compounds (44% B and 50 8C) the organic modifier. The flow-rate was at 1.5 ml/ min and column temperature at 50 8C. The resolution map (Fig. 4) showed a maximal resolution (R s$4) for conditions of 50 60% B and ph 5.0, at the cost of long run times (25 70 min, not shown on the resolution map). This condition could provide an option for further optimization of column parameters in order to shorten the run time (see It is interesting to note the change in the elution order for the main peak (peak 5) and one of its Peak I.D. Retention time (min) Resolution section below). At the current column conditions, an DryLab Exp. DryLab Exp. optimal Rs of 2.1 and run time of less than 10 min 1 5.37 5.38 2.8 2.5 were obtained at 70% B and ph 5.0. Table 3 shows 2 5.84 5.82 32.3 33.3 the predicted and experimental data for the optimized separation at 70% B and ph 5.0. A good agreement between the predicted and experimental values was obtained with average errors of 0.9 and 6.3% for retention time and resolution, respectively. 3 16.66 16.50 3.4 3.6 4 18.22 18.45 3.6 3.8 5 20.53 20.30 NA NA Average 0.8 6.6 % error NA, not applicable.

T.H. Hoang et al. / J. Chromatogr. A 991 (2003) 281 287 285 Fig. 4. Resolution map obtained with simultaneous optimization of organic content and ph. Cross-hair marks the region with optimal R. s degradation peaks (peak 4) in the ph range of 4 5. It may be due to the impact of ph on the retention of the main peak since it possesses an acidic functional group, while the retention of peak 4 was almost unchanged with ph, probably due to the absence of the acidic group. 3.5. Optimization of column conditions As mentioned in the previous section, the conditions for maximal Rs were 50 60% B and ph 5.0, Table 3 A comparison of predicted and experimental retention data for the with run time of 25 70 min. DryLab can be used to optimized separation of model compounds (70% B and ph 5) model changes in the separation when column Peak I.D. Retention time (min) Resolution parameters, such as column length, particle size and flow-rate, are varied. The goal was to achieve DryLab Exp. DryLab Exp. adequate resolution, acceptable column pressure and 1 2.11 2.08 2.09 1.90 minimum run time. Fig. 5 shows predicted chromato- 2 2.28 2.25 18.86 19.11 grams obtained at 60% B and ph 5.0 when (A) 3 4.51 4.53 6.95 7.88 5 5.72 5.80 10.80 12.26 flow-rate was increased to 2 ml/min (B) the column 4 8.37 8.37 NA NA length was changed from 15 to 5 cm and (C) Average 0.9 6.3 simultaneous change in column length and flow-rate. % error In all cases, the resolution was reported to be of at NA, not applicable. least 1.6 for the critical pair (peaks 1 and 2) and the

286 T.H. Hoang et al. / J. Chromatogr. A 991 (2003) 281 287 Fig. 5. Predicted chromatograms of the separation when (A) flow-rate was changed from 1.5 to 2 ml/ min, (B) column length changed from 15 to 5 cm, (C) simultaneous change in column length from 15 to 5 cm and flow-rate from 1.5 to 2 ml/min. run time was less than 6 min when both column 4. Conclusion length and flow-rate were modified (C). To validate the prediction, an experiment was therefore carried The DryLab simulation software was demonstraout using a 5-cm column (of different lot) and a ted to be a useful tool for optimizing the separation flow-rate of 2 ml/ min. The results showed a satisfac- of the model drug candidate and its degradation tory agreement between the predicted and ex- products. After appropriate column selection and perimental values, with average errors of 3.5 and with a minimum number of experimental runs, 11.8% for retention time and resolution, respectively. accurate predictions for a broad range of separation The greater percent errors in the predictions were conditions could be achieved. This could lead to probably due to small k9 and column-to-column substantial timesaving and more effective use of staff variation [6 8]. and resources. In addition, the software is an excel-

T.H. Hoang et al. / J. Chromatogr. A 991 (2003) 281 287 287 lent instructional tool for users who are new to References chromatography. DryLab software comes equipped with a number of sample data files that allows the [1] T. Baczek, R. Kaliszan, H.A. Claessens, M.A. van Straten, new users to familiarize themselves with the vari- LC?GC Europe June (2001) 2 6. ables affecting a separation. The learning curve can [2] J. Schmidt, J. Chromatogr. 485 (1989) 421. [3] L.R. Snyder, J.W. Dolan, D.C. Lommen, J. Chromatogr. 485 be shortened by replacing long instrument runs with (1989) 65. rapid simulation and immediate feedback. [4] P. Haber, T. Baczec, R. Kaliszan, L.R. Snyder, J.W. Dolan, C.T. Wehr, J. Chromatogr. Sci. 38 (2000) 386. [5] T.H. Jupille, J.W. Dolan, L.R. Snyder, I. Molnar, J. Chromatogr. A 948 (2002) 35. [6] J.A. Lewis, D.C. Lommen, W.D. Raddatz, J.W. Dolan, L.R. Acknowledgements Snyder, J. Chromatogr. 592 (1992) 183. [7] M. Lammerhofer, P. Di Eugenio, I. Molnar, W. Lindner, J. The authors wish to thank Dr. E. Kwong for Chromatogr. A 689 (1997) 123. kindly reviewing the manuscript. [8] R.G. Lehmann, J.R. Miller, J. Chromatogr. 485 (1989) 581.